Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.20.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Accumulated Deficit
Additional Paid-in Capital
Common Stock
Beginning balance at Aug. 31, 2018 $ 81,638 $ (23,358) $ 104,918 $ 78
Beginning balance (in shares) at Aug. 31, 2018       78,273
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 2,297   2,297  
Stock-based compensation (in shares)       5
Stock option exercises 42   41 $ 1
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period       281
Net loss (8,579) (8,579)    
Ending balance at Nov. 30, 2018 75,398 (31,937) 107,256 $ 79
Ending balance (in shares) at Nov. 30, 2018       78,559
Beginning balance at Aug. 31, 2018 81,638 (23,358) 104,918 $ 78
Beginning balance (in shares) at Aug. 31, 2018       78,273
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock issued for acquisitions 141      
Stock issued for equity investment 0      
Net loss (28,092)      
Ending balance at May. 31, 2019 103,537 (51,450) 154,898 $ 89
Ending balance (in shares) at May. 31, 2019       88,840
Beginning balance at Nov. 30, 2018 75,398 (31,937) 107,256 $ 79
Beginning balance (in shares) at Nov. 30, 2018       78,559
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 3,178   3,178  
Stock-based compensation (in shares)       125
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period       89
Stock sold to investors 41,593   41,584 $ 9
Stock sold to investors (in shares)       9,077
Stock issued for acquisitions 140   140  
Stock issued for acquisitions (In shares)       162
Net loss (8,915) (8,915)    
Ending balance at Feb. 28, 2019 111,394 (40,852) 152,158 $ 88
Ending balance (in shares) at Feb. 28, 2019       88,012
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 2,741   2,740 $ 1
Stock-based compensation (in shares)       328
Stock issued for acquisitions (In shares)       500
Net loss (10,598) (10,598)    
Ending balance at May. 31, 2019 103,537 (51,450) 154,898 $ 89
Ending balance (in shares) at May. 31, 2019       88,840
Beginning balance at Aug. 31, 2019 101,354 (62,994) 164,258 $ 90
Beginning balance (in shares) at Aug. 31, 2019       90,041
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 3,189 0 3,189  
Stock-based compensation (in shares)       99
Stock sold to investors 27,379   27,362 $ 17
Stock sold to investors (in shares)       17,198
Stock issued for acquisitions (In shares)       23
Net loss (12,506) (12,506)    
Ending balance at Nov. 30, 2019 119,416 (75,500) 194,809 $ 107
Ending balance (in shares) at Nov. 30, 2019       107,361
Beginning balance at Aug. 31, 2019 101,354 (62,994) 164,258 $ 90
Beginning balance (in shares) at Aug. 31, 2019       90,041
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock issued for acquisitions 0      
Stock issued for equity investment 2,528      
Net loss (70,368)      
Ending balance at May. 31, 2020 84,875 (133,362) 218,117 $ 120
Ending balance (in shares) at May. 31, 2020       119,933
Beginning balance at Nov. 30, 2019 119,416 (75,500) 194,809 $ 107
Beginning balance (in shares) at Nov. 30, 2019       107,361
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 3,141   3,141  
Stock-based compensation (in shares)       89
Issuance of restricted stocks (in shares)       15
Stock sold to investors 14,716   14,706 $ 10
Stock sold to investors (in shares)       10,000
Stock issued for equity investment 2,528   2,526 $ 2
Stock issued for equity investment (Shares)       1,653
Net loss (44,375) (44,375) 0 $ 0
Ending balance at Feb. 29, 2020 95,426 (119,875) 215,182 $ 119
Ending balance (in shares) at Feb. 29, 2020       119,118
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 2,936   2,936  
Stock-based compensation (in shares)       353
Issuance of restricted stocks     (1) $ 1
Issuance of restricted stocks (in shares)       462
Net loss (13,487) (13,487)    
Ending balance at May. 31, 2020 $ 84,875 $ (133,362) $ 218,117 $ 120
Ending balance (in shares) at May. 31, 2020       119,933